Taken together, our data uncover the implications of a SOX2-regulated gene expression network controlling cancer aggressiveness via FOSL2 by activating and sustaining pro-inflammatory TME leading to DNA damage and genomic instability. The gene discussed is SOX2; the disease is cancer.